Marvel Biosciences Corp (MRVL : TSX-V)
Common Stock
$0.12
CAD
+0.01 (9.52%)
Last updated: 2026-10-08
Follow MRVL
MRVL
Marvel Biosciences Corp
WealthAwesomePerformance
1 Day
+9.52%
1 Week
-23.33%
1 Month
-17.86%
YTD
-14.81%
Key Statistics
Market Cap
$7.74M
52W High
$0.25
52W Low
$0.10
P/E Ratio
-
50 Day MA
$0.15
200 Day MA
$0.15
Beta
0.49
Dividend Yield
-
Advertisement
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 10/8/2026 | $0.10 | $0.12 | $0.10 | $0.12 | $0.12 | 148,996 |
| 10/7/2026 | $0.12 | $0.12 | $0.10 | $0.10 | $0.10 | 88,392 |
| 10/6/2026 | $0.11 | $0.12 | $0.11 | $0.11 | $0.11 | 177,779 |
| 10/5/2026 | $0.12 | $0.12 | $0.10 | $0.11 | $0.11 | 226,209 |
| 10/2/2026 | $0.15 | $0.15 | $0.12 | $0.12 | $0.12 | 474,666 |
| 10/1/2026 | $0.15 | $0.15 | $0.15 | $0.15 | $0.15 | 14,358 |
| 9/30/2026 | $0.15 | $0.16 | $0.15 | $0.15 | $0.15 | 27,118 |
| 9/29/2026 | $0.14 | $0.15 | $0.14 | $0.15 | $0.15 | 176,922 |
| 9/28/2026 | $0.15 | $0.15 | $0.14 | $0.15 | $0.15 | 21,841 |
| 9/25/2026 | $0.15 | $0.15 | $0.15 | $0.15 | $0.15 | 3,500 |
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on MRVL's historical volatility
30-Day Vol
86.4%
Annualized
90-Day Vol
128.2%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$0.10
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.11 | C$0.08 – C$0.15 |
| 60 trading days | C$0.10 | C$0.07 – C$0.16 |
| 90 trading days | C$0.10 | C$0.06 – C$0.16 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Marvel Biosciences Corp
Marvel Biosciences Corp., a biotechnology company, develops synthetic chemical derivatives of the original approved drug for the new disease indication in Canada. The company's lead compound MB-204, a novel fluorinated derivative of istradefylline, an adenosine A2a receptor antagonist to treat alzheimer's disease and autism spectrum disorder, as well as depression and anxiety. It provides non-hallucinogenic neuroplasticity program. The company is headquartered in Calgary, Canada.
Financials
- Revenue (TTM)
- $0
- EBITDA
- $-2.19M
- Profit Margin
- 0.00%
- ROE (TTM)
- -380.30%
- EPS (Diluted)
- -0.03
- Book Value
- -0.04
Classification
- Sector
- Health Care
- Industry
- Biotechnology
- Group
- Pharmaceuticals, Biotechnology & Life Sciences
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Advertisement
Common Questions About MRVL
Market movers
Recent TSX-V movers
Top 1-day gainers — updated from our Canadian movers feed.
| Ticker | Name | Price | 1D |
|---|---|---|---|
| PPM | Pacific Imperial Mines Inc | $0.30 | +900.00% |
| JSPX | JasperX Technologies Inc. | $0.14 | +61.11% |
| RIWI | Riwi Corp | $0.22 | +29.41% |
| AZEM | Arizona Eagle Mining Corp. | $0.80 | +25.00% |
| DBAY | Elton Resources Corp. | $0.20 | +25.00% |
| OTMC | Oreterra Metals Corp. | $0.35 | +22.81% |
| BPR | Black Pine Resources Corp. | $0.11 | +22.22% |
| EFF | 1844 Resources Inc | $0.03 | +20.00% |
MRVL.V news timeline
9 articles covering MRVL.V, most recent first
Latest